Patent · US Expired

Glycolipid compositions for transplanted tumor immunotherapy

US4243663A · kind A · utility

11Cited by
4References
11Claims
0Family size

Inventors

Key dates

Filing dateAug 4, 1978
Grant dateJan 6, 1981
Priority date—
Expiry dateAug 4, 1998

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55572
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A composition which is capable of specifically inducing an immunity when administered into the body of a host in association with a tumor antigen, or which is capable of non-specifically enhancing an immunizing function when administered into the body of a tumor-carrying host, comprising a glycolipid as active ingredient in association with a pharmaceutically acceptable carrier, wherein the saccharide moiety of the glycolipid is selected from the group consisting of fructose, glucose and sucrose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.